Abstract
Hypertension is a well-known major risk factor for cardiovascular diseases. This study has been designed to assess the prevalence of hypertension, its co-occurrence with other cardiovascular risk factors and its association with cardiovascular diseases in a representative sample of Lebanese population. A pretested questionnaire was administered to 2125 adults aged equal or above 30 years old from all regions in Lebanon and proportionate with the respective population density. Data revealed that 23.1% of the respondents admitted being hypertensive, with no statistically significant difference between male and female patients. Prevalence of hypertension increased with age (P<0.01) and hypertension tended to occur more in the less educated and the unemployed (P<0.01). Only 45.7% of hypertensive patients followed a low fat diet while 14.7% exercised daily. The prevalence of hypertension increased significantly with an increase in body mass index particularly in female patients. Among the hypertensive respondents, 23.9% were diabetic, 38.1% were hyperlipidaemic and 9.1% were both diabetic and hyperlipidaemic. Co-occurrence of hypertension with diabetes, hyperlipidaemia or both was more common in female patients compared to male patients. In addition, stroke, myocardial infarction (MI) and atherothrombosis occurred in hypertensive respondents at rates of 2.4, 4.3 and 9.5%, respectively. Hypertensive female patients reported more stroke and atherothrombotic episodes compared to male patients, whereas hypertensive male patients had more MIs. Based on these results it is very important to address the issue of lifestyle modification for the prevention and treatment of hypertension and awareness campaigns should stress the fact that cardiovascular diseases are not only restricted to men.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
World Health Report 2002. Reducing Risk, Promoting Healthy Life. Geneva, Switzerland: World Health Organization 2002. http://www.who.int/whr/2002/chapter4/en/index4.html.
Banegas JR et al. Mortality attributable to cardiovascular risk factors in Spain. Eur J Clin Nutr 2003; 57(Suppl): 518–521.
Onwuyani AE, Clarke A, Vanderbush E . Cardiovascular disease mortality. J Natl Med Assoc 2003; 95(12): 1146–1151.
Kannel WB et al. Role of blood pressure in the development of congestive heart failure: The Framingham Study. N Engl J Med 1972; 287: 781–787.
Levy D et al. The progression from hypertension to congestive heart failure. JAMA 1996; 275: 1557–1562.
Bener A, Al-suwaidi J, El Menya A, Gehani A . The effect of hypertension as a predictor of risk for congestive heart failure patients over a 10-year period in a newly developed country. Blood Pressure 2004; 13(1): 41–46.
Mac Mahon S et al. Blood pressure, stroke and coronary heart disease. Part I. prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765–774.
Prospective Studies Collaboration. Cholesterol, diastolic blood pressure & stroke: 13000 strokes in 450000 people in 45 prospective cohorts. Lancet 1995; 346: 1647–1653.
Kannel WB, Wolf PA, Verter J, Mc Namara PM . Epidemiologic assessment of the role of blood pressure in stroke: The Framingham Study. JAMA 1970; 214: 301–310.
Chobanian AV, et al., The National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206–1252.
Watkins LO . Epidemiology and burden of cardiovascular disease. Clin Cardiol 2004; 27(26 Suppl 3): III2–III6.
Okrainec K, Banerjee D, Eisenberg M . Coronary artery disease in the developing world. Am Heart J 2004; 148(1): 7–15.
Omran AR . The Epidemiologic Transition: a theory of the epidemiology of population change. Milbank Memorial Fund Q 1971; 49: 509–538.
Dodu SRA . Emergence of cardiovascular diseases in developing countries. Cardiology 1988; 75: 56–64.
Ebrahim S, Smith GD . Exporting failure? coronary heart disease and stroke in developing countries. Int J Epidemiol 2001; 30: 201–205.
United Nations Fund for Population Activities and the Ministry of Social Affairs. Statistical Tables for the Population and Housing census, 1994–1996. Beirut: MOSA 1997.
Sibai AM, Fletcher A, Hills H, Campbell O . Non-communicable disease mortality rates using the verbal autopsy in a cohort of middle-aged and older populations in Beirut during wartime 1983–93. J Epidemiol Community Health 2001; 55: 271–276.
Nakkash R et al. The development of a feasible community specific cardiovascular disease prevention program: triangulation of methods and sources. Health Educ Behav 2003; 30(6): 723–739.
Salti I et al. Epidemiology of cardiovascular risk factors among adult lebanese population. Lebanese Tech Rep 1998; (4): 1–72.
Salti I et al. Epidemiology of diabetes mellitus in relation to other cardiovascular risk factors in Lebanon. East Mediterranean Health J 1997; 3(3): 462–471.
Ghannem H, Hadj Fredj A . Epidemiology of hypertension and other cardiovascular disease risk factors in the urban population of Soussa, Tunisia. East Mediterranean Health J 1997; 3(3): 472–479.
Sarafidis PA et al. Prevalence, awareness, treatment and control of hypertension in employees of factories of northern Greece: the Naoussa Study. J Hum Hypertens 2004; 18(9): 623–629.
Onal AE et al. The prevalence of and risk factors for hypertension in adults living in Istanbul. Blood Pressure 2004; 13(1): 31–36.
Bener A et al. The prevalence of hypertension and its associated risk factors in a newly developed country. Saudi Med J 2004; 25(7): 918–922.
Mafawzy M, Mokhtar N, Wan Mohammad WB . Hypertension and associated cardiovascular risk factors in Kelantan. Med J Malaysia 2003; 58(4): 556–564.
Tanuseputro P et al. Canadian cardiovascular outcomes research team, risk factors for cardiovascular disease in Canada. Can J Cardiol 2003; 19(11): 1249–1259.
Srinivasan SR, Myers L, Berenson GS . Predictability of childhood adiposity and insulin for developing insulin resistance syndrome (syndrome X) in young adulthood: The Bogalusa Heart Study. Diabetes 2002; 51: 204–209.
Mahoney LT, Clarke WR, Burns TL, RM . Childhood predictors of high blood pressure. Am J Hypertens 1991; 4: 608S–610S.
Sacks FM et al. Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet: DASH-Sodium Collaborative Research group. N Engl J Med 2001; 344: 3–10.
Bacon S, Sherwood A, Hinderliter A, Blumenthal J . Effects of exercise, diet & weight loss on high blood pressure. Sports Med 2004; 34(5): 307–316.
Sibai AM, Hwalla N, Adra N, Rahal B . Prevalence and covariates of obesity in Lebanon: findings from the first epidemiologic study. Obes Res 2003; 11(11): 1353–1361.
Mokdad A et al. Prevalence of obesity, diabetes and obesity-related health risk factors, 2001. JAMA 2003; 289(1): 76–79.
Castelli WP, Anderson KA . A population at risk: prevalence of high cholesterol levels in hypertensive patients in the Framingham Study. Am J Med 1986; 80: 23–32.
Stamler J, Wentworth D, Neaton JD . Prevalence & prognostic significance of hypercholesterolemia in men with hypertension: prospective data on the primary screenees of the multiple risk factor intervention trial. Am J Med 1986; 80: 33–39.
Verschuren WM et al. Serum total cholesterol and long term coronary heart disease mortality in different cultures: twenty five-year follow up of the seven countries study. JAMA 1995; 274: 131–136.
Haffner SM et al. Mortality from coronary heart disease in subjects with type2 diabetes and in non-diabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339: 229–234.
Adler AI et al. Association of systolic blood pressure with macrovascular & microvascular complications of type 2 diabetes (UKPDS 36): Prospective Observational Study. BMJ 2000; 321: 412–419.
Barrett-Connor E et al. Women & heart disease: the role of diabetes and hyperglycemia. Arch Intern Med 2004; 164: 934–942.
Rowland ML . Self reported weight and height. Am J Clin Nutr 1990; 52: 1125–1133.
Palta M, Prineas RJ, Berman R, Hannan P . Comparison of self reported and measured height and weight. Am J Epidemiol 1982; 115: 223–230.
Halabi S et al. Reliability & validity of self and proxy reporting of morbidity data: A case Study from Beirut, Lebanon. Int J Epidemiol 1992; 21: 607–612.
Heliovaara M et al. Reliability and validity of interview data on chronic diseases: The mini-Finland Health Survey. J Clin Epidemiol 1993; 46(2): 181–191.
Wu SC, Li CY, Ke DS . The agreement between self reporting and clinical diagnosis for selected medical conditions among the elderly in Taiwan. Public Health 2000; 114: 137–142.
Tormo MJ, Navarro C, Chirlaque MD, Barber X, the EPIC group of Spain. Validation of self-diagnosis of high blood pressure in a sample of the Spanish EPIC cohort: overall agreement and predictive values. J Epidemiol Community Health 2000; 54: 221–226.
Okura Y et al. Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. J Clin Epidemiol 2004; 57: 1096–1103.
Haapanen N et al. Agreement between questionnaire data and medical records of chronic diseases in middle-aged and elderly Finish men and women. Am J Epidemiol 1997; 145: 762–769.
Hunink MG et al. The recent decline in mortality from coronary heart disease, 1980–1990: the effect of secular trends in risk factors & treatment. JAMA 1997; 277: 535–542.
Capewell S, Beaglehole R, Seddon M, McMurray J . Explanation for the decline in coronary heart disease mortality rates in Auckland, New Zealand, between 1982 and 1993. Circulation 2000; 102: 1511–1516.
Capewell S, Morrison CE, McMurray JT . Contribution of modern cardiovascular treatment & risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994. Heart 1999; 81: 380–386.
Belgin U, Gitchley JA, Capewell S . Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation 2004; 109(9): 1101–1107.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tohme, R., Jurjus, A. & Estephan, A. The prevalence of hypertension and its association with other cardiovascular disease risk factors in a representative sample of the Lebanese population. J Hum Hypertens 19, 861–868 (2005). https://doi.org/10.1038/sj.jhh.1001909
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jhh.1001909
Keywords
This article is cited by
-
Hypertension in the Middle East: current state, human factors, and barriers to control
Journal of Human Hypertension (2022)
-
Long-term Trends in Hypertension Prevalence, Awareness, Treatment, and Control Rate in the Middle East and North Africa: a Systematic Review and Meta-analysis of 178 Population-Based Studies
Current Hypertension Reports (2021)
-
The cascade of care in managing hypertension in the Arab world: a systematic assessment of the evidence on awareness, treatment and control
BMC Public Health (2020)
-
Type 2 diabetes and pre-diabetes mellitus: a systematic review and meta-analysis of prevalence studies in women of childbearing age in the Middle East and North Africa, 2000–2018
Systematic Reviews (2019)
-
Physical inactivity, gender and culture in Arab countries: a systematic assessment of the literature
BMC Public Health (2018)